News
-
-
COMMUNIQUÉ DE PRESSE
Secarna Pharmaceuticals publishes new data in Nucleic Acid Therapeutics showcasing strategies to detect and prevent immunostimulatory potential of LNA-modified ASOs
Secarna Pharmaceuticals publishes new data in Nucleic Acid Therapeutics highlighting strategies to detect and prevent immunostimulatory potential of LNA-modified ASOs -
-
-
COMMUNIQUÉ DE PRESSE
Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics
Secarna Pharmaceuticals and Orbit Discovery collaborate to develop peptide-conjugated targeted antisense oligonucleotide therapeutics, expanding treatment options for various diseases -
-
-
-
-
